GlassScriptPhysician profile
Leah C Folb
NPI 1457517385
$10,238.58
in general payments reported to CMS, 2019-2025
46 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what 75% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,326 · 2020: $435 · 2021: $1,072 · 2022: $612 · 2023: $1,654 · 2024: $1,353 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,793.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,476.23 | 2019-2025 | Evenity, Prolia, Repatha |
| Valeritas, INC. | $821.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $716.76 | 2019-2025 | |
| Abbott Laboratories | $697.73 | 2019-2025 | Freestyle Libre, Freestyle Libre 3 |
| Dexcom, INC. | $661.39 | 2019-2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $590.13 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $495.15 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $478.84 | 2019-2022 | |
| Radius Health, INC. | $388.99 | 2019-2025 | Tymlos |
| Novo Nordisk INC | $378.87 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $289.96 | 2019-2025 | Omnipod |
| Abbvie INC. | $234.54 | 2021-2025 | |
| Sequel Med Tech, LLC | $231.08 | 2025 | Twiist |
| Neurocrine Biosciences, INC. | $203.84 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $189.21 | 2021-2023 | Gvoke Hypopen |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Folb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.